# Methylphenidate

## Concerta ER 27mg

| TAH Drug Code      | [**OCON2**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OCON2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | For treatment of attention deficit hyperactivity disorder.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Dosing             | Attention deficit disorder : (Child over 6 years and adult) Concerta: 27mg(1 TAB) QD. ( maximum for Child: 54 mg/day; maximum for adult : 72 mg/day )                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | Patients with marked anxiety, tension & agitation, glaucoma, Tourette's syndrome, & patients on MAOI therapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | Headache, stomach ache, loss of appetite, insomnia, aggravation reaction, asthenia, hypertension, nausea &/or vomiting, dyspepsia, weight loss, twitching (tics), dizziness, emotional lability, somnolence, anxiety, depression, nervousness, hostility, rash. Dermatologic: Erythema Endocrine metabolic: Weight decreased (9% ) Gastrointestinal: Decrease in appetite (26% ), Loss of appetite (5% ), Nausea (12% ), Vomiting (10% ) Neurologic: Headache, Insomnia (13% ) Psychiatric: Labile affect (6% ) Respiratory: Nasal congestion (6% ), Nasopharyngitis (5% ) |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

## CONCERTA 36mg

| TAH Drug Code      | [**OCON3**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OCON3)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | For treatment of attention deficit hyperactivity disorder.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Dosing             | Attention deficit disorder : (Child over 6 yrs and adult) Concerta: 36mg(1 TAB) QD. (maximum for Child: 54 mg/day; maximum for adult : 72 mg/day )                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | Patients with marked anxiety, tension & agitation, glaucoma, Tourette's syndrome, & patients on MAOI therapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | Headache, stomach ache, loss of appetite, insomnia, aggravation reaction, asthenia, hypertension, nausea &/or vomiting, dyspepsia, weight loss, twitching (tics), dizziness, emotional lability, somnolence, anxiety, depression, nervousness, hostility, rash. Dermatologic: Erythema Endocrine metabolic: Weight decreased (9% ) Gastrointestinal: Decrease in appetite (26% ), Loss of appetite (5% ), Nausea (12% ), Vomiting (10% ) Neurologic: Headache, Insomnia (13% ) Psychiatric: Labile affect (6% ) Respiratory: Nasal congestion (6% ), Nasopharyngitis (5% ) |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

## apo-Methylphenidate 10mg

| TAH Drug Code      | [**OMET1**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OMET1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Attention-deficit hyperactivity disorder; narcolepsy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | Children >= 6 years: Initially 5 mg QD or BID with gradual increments of 5-10 mg weekly. maximum: 60 mg/day.Adult: 10 to 60 mg/day divided 2 to 3 times, preferably 30 to 45 minutes before meals. If the patient is unable to fall asleep due to taking the medicine late, the last dose should be taken before 6 pm. If no improvement in symptoms is seen after an appropriate dose adjustment for more than one month, the drug should be discontinued.                                                                                                                                                                                 |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Anxiety & tension states, agitation, tics, tics in siblings, family history or diagnosis of Tourette's syndrome; glaucoma; hyperthyroidism; cardiac arrhythmias, severe angina pectoris.                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Adverse Effects    | Frequent: nervousness, insomnia, decreased appetite. Occasional: headache, drowsiness, dizziness, dry mouth, tachycardia, palpitations, arrhythmias, changes in BP & heart rate; GI disturbances, skin reactions, fever, arthralgia. Rare: blurred vision, moderately reduced weight gain & minor growth retardation in children. Dermatologic: Erythema Endocrine metabolic: Weight decreased (9% ) Gastrointestinal: Decrease in appetite (26% ), Loss of appetite (5% ), Nausea (12% ), Vomiting (10% ) Neurologic: Headache, Insomnia (13% ) Psychiatric: Labile affect (6% ) Respiratory: Nasal congestion (6% ), Nasopharyngitis (5%) |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

## Ritalin LA 20mg

| TAH Drug Code      | [**ORIT2**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ORIT2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Attention-deficit hyperactivity disorder; narcolepsy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Dosing             | Children >= 6 years (immediate-release Tablets) Initially 10mg. Dose adjustment can be based on the observed tolerance and therapeutic effect with gradual increments of 10 mg weekly. maximum: 40 mg/day. Adult: 20 mg QD initially.maximum: 60 mg/day.Ritalin LA sustained action capsules can be adjusted by increasing the dosage by 10 mg weekly. Immediate-release Tablets convert to extended-release Tablets: 5mg methylphenidate BID (immediate-release TABlets) is equivalent to 10mg methylphenidate(extended release Tablets) QD.10mg methylphenidate BID (immediate-release Tablets) is equivalent to 20mg methylphenidate(extended release Tablets) QD. 15mg methylphenidate BID (immediate-release TABlets) is equivalent to 30mg methylphenidate(extended release Tablets) QD. 20mg methylphenidate BID (immediate-release Tablets) is equivalent to 40mg methylphenidate(extended release Tablets) QD. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | Anxiety & tension states, agitation, tics, tics in siblings, family history or diagnosis of Tourette's syndrome; glaucoma; hyperthyroidism; cardiac arrhythmias, severe angina pectoris.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Adverse Effects    | Frequent: nervousness, insomnia, decreased appetite. Occasional: headache, drowsiness, dizziness, dry mouth, tachycardia, palpitations, arrhythmias, changes in BP & heart rate; GI disturbances, skin reactions, fever, arthralgia. Rare: blurred vision, moderately reduced weight gain & minor growth retardation in children. Dermatologic: Erythema Endocrine metabolic: Weight decreased (9% ) Gastrointestinal: Decrease in appetite (26% ), Loss of appetite (5% ), Nausea (12% ), Vomiting (10% ) Neurologic: Headache, Insomnia (13% ) Psychiatric: Labile affect (6% ) Respiratory: Nasal congestion (6% ), Nasopharyngitis (5% )                                                                                                                                                                                                                                                                            |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

